ClinicalTrials.Veeva

Menu

Isomil Post Marketing Observational Study

M

Melva Louisa

Status

Completed

Conditions

Cow's Milk Allergy

Study type

Observational

Funder types

Other

Identifiers

NCT01809951
ANID-1101

Details and patient eligibility

About

The use of soy-isolate protein based formula for infants with cow's milk protein intolerance is common in Indonesia, however, there has not been any systematic collection of clinical data to determine the formula's gastrointestinal tolerance, and the parent's perceptions regarding the formula.

Enrollment

534 patients

Sex

All

Ages

6 to 12 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • infants of 6 - 12 months of age
  • full term infants
  • birth weight more than 2500 grams
  • infants developed symptoms suggestive adverse reactions to cow's milk protein in the investigator's clinical judgements
  • subject is prescribed a soy-based infant formula by physician

Exclusion criteria

  • established/suspected hypersensitivity fo soy
  • presence of adverse reactions to cow's milk caused by coincidental infections or other systemic disease
  • history of blood group incompatibility, premature delivery, HIV infections, major congenital abnormalities, systemic diseases
  • presence of severe gastrointestinal disorder
  • subject is participating in any interventional clinical study

Trial design

534 participants in 1 patient group

Isomil Advance with LCP
Description:
4 spoonful of Isomil Advance with LCP in 240 mL of water, 4 times a day

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems